M6A methylation modification in autoimmune diseases, a promising treatment strategy based on epigenetics. Huang Y, Xue Q, Chang J, Wang Y, et al. Arthritis Res Ther 2023;25:189.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Huang Y, Xue Q, Chang J, Wang Y, et al. M6A methylation modification in autoimmune diseases, a promising treatment strategy based on epigenetics. Arthritis Res Ther 2023;25:189.
PMID: 37784134